13-week subchronic toxicity study of a novel ginsenoside composition from ginseng leaves in rats
暂无分享,去创建一个
[1] Yun-Bae Kim,et al. Anti-Helicobacter pylori activities of FEMY-R7 composed of fucoidan and evening primrose extract in mice and humans , 2014, Laboratory animal research.
[2] D. M. Zancan,et al. Experimental model of tympanic colic (acute abdomen) in chinchillas (Chinchilla lanigera) , 2014, Laboratory animal research.
[3] Yanchun Deng,et al. Ginsenoside Rd blocks AIF mitochondrio-nuclear translocation and NF-κB nuclear accumulation by inhibiting poly(ADP-ribose) polymerase-1 after focal cerebral ischemia in rats , 2013, Neurological Sciences.
[4] H. Yoo,et al. Metabolite profiling of ginsenoside Re in rat urine and faeces after oral administration. , 2013, Food chemistry.
[5] H. Chung,et al. Ginsenoside Rd inhibits the expressions of iNOS and COX-2 by suppressing NF-κB in LPS-stimulated RAW264.7 cells and mouse liver , 2013, Journal of ginseng research.
[6] Wenjie Zhao,et al. Chronic toxicity of ginsenoside Re on Sprague-Dawley rats. , 2012, Journal of ethnopharmacology.
[7] R. Nicholson,et al. Toxicity of a novel anti-tumor agent 20(S)-ginsenoside Rg3: a 26-week intramuscular repeated administration study in rats. , 2011, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[8] K. Leung,et al. Pharmacology of ginsenosides: a literature review , 2010, Chinese medicine.
[9] Jian-Guo Sun,et al. Pharmacokinetic characterization of ginsenoside Rh2, an anticancer nutrient from ginseng, in rats and dogs. , 2009, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[10] Seon-Gil Do,et al. UG0712, A Novel Ginsenoside Composition Enhances the Endurance Exercise Capacity and Fatigue Recovery , 2009 .
[11] Jingwei Tian,et al. 20(S)‐ginsenoside Rg3, a neuroprotective agent, inhibits mitochondrial permeability transition pores in rat brain , 2009, Phytotherapy research : PTR.
[12] J. Wan,et al. Chemical characteristics for different parts of Panax notoginseng using pressurized liquid extraction and HPLC-ELSD. , 2006, Journal of pharmaceutical and biomedical analysis.
[13] Chong-Zhi Wang,et al. Saponins composition in American ginseng leaf and berry assayed by high-performance liquid chromatography. , 2006, Journal of agricultural and food chemistry.
[14] Jingwei Tian,et al. Neuroprotective effect of 20(S)-ginsenoside Rg3 on cerebral ischemia in rats , 2005, Neuroscience Letters.
[15] S. Ko,et al. Effects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cells , 2004, Archives of pharmacal research.
[16] K. Jang,et al. The effect of Korean red ginseng on liver regeneration after 70% hepatectomy in rats. , 2004, The Journal of veterinary medical science.
[17] K. Jang,et al. The effects of Korean red ginseng (ginseng radix rubra) on liver regeneration after partial hepatectomy in dogs. , 2003, Journal of veterinary science.
[18] T K Yun,et al. Brief introduction of Panax ginseng C.A. Meyer. , 2001, Journal of Korean medical science.
[19] M. Mateenuddin,et al. Subacute toxicity study of the combination of ginseng (Panax ginseng) and ashwagandha (Withania somnifera) in rats: a safety assessment. , 1998, Indian journal of physiology and pharmacology.
[20] G. Kissling,et al. Two-year toxicity and carcinogenicity studies of Panax ginseng in Fischer 344 rats and B6C3F1 mice. , 2011, The American journal of Chinese medicine.
[21] R. Nicholson,et al. Toxicity of a novel anti-tumor agent 20(S)-ginsenoside Rg3: a 26-week intramuscular repeated administration study in Beagle dogs. , 2011, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[22] David Kiefer,et al. Panax ginseng , 2009 .